Tumor necrosis factor‑related apoptosis‑inducing ligand as a therapeutic option in urothelial cancer cells with acquired resistance against first‑line chemotherapy-Reference-Cited by-同舟云学术

Tumor necrosis factor‑related apoptosis‑inducing ligand as a therapeutic option in urothelial cancer cells with acquired resistance against first‑line chemotherapy

Published:2020-02-03 Issue: Volume: Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Vallo Stefan¹,Stege Henner¹,Berg Maximilian¹,Michaelis Martin²,Winkelmann Ria³,Rothweiler Florian¹,Cinatl Jindrich¹

Affiliation:

1. Institute of Medical Virology, University Hospital Frankfurt, D‑60596 Frankfurt am Main, Germany

2. Centre for Molecular Processing and School of Biosciences, University of Kent, CT2 7NZ Canterbury, UK

3. Dr. Senckenberg Institute of Pathology, University Hospital Frankfurt, D‑60596 Frankfurt am Main, Germany

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Association of Death Receptors and TGF-β1 Expression in Urothelial Bladder Cancer and Their Prognostic Significance;Biomedicines;2024-05-18

2. Efficient treatment of colon cancer with codelivery of TRAIL and imatinib by liposomes;Pharmaceutical Development and Technology;2024-01-02

3. Inhibitor of apoptosis proteins as therapeutic targets in bladder cancer;Frontiers in Oncology;2023-02-10

4. Functionalized drug-gene delivery materials to transport inhibitor of apoptosis protein antagonists for tumor malignancy management;Journal of the Taiwan Institute of Chemical Engineers;2022-04

5. A self-sustained nanoplatform reverses TRAIL-resistance of pancreatic cancer through coactivating of exogenous and endogenous apoptotic pathway;Biomaterials;2021-05